QUANTERIX CORP

Quanterix insider deal: CCO James Edward Jr. receives 260k RSUs, signaling leadership’s confidence and aligning incentives for future growth.

Quanterix insider buying shows steady confidence in its high‑sensitivity diagnostics, especially in oncology and neurology, boosting investor optimism.

Insider buying at Quanterix signals confidence amid volatility—Thomas’s recent purchase hints at a potential rebound in the company’s diagnostics pipeline.

Quanterix COO’s big share purchases signal confidence ahead of product launch—insider buying could spark a short‑term rally. Discover the strategy.

Quanterix insider deals reveal new RSU and option grants for C‑level executive, signaling long‑term confidence amid short‑term trade volatility and market headwinds.

Insider buying at Quanterix shows CFO Sriram Vandana’s confidence in a potential FDA‑cleared Alzheimer’s test, hinting at upside amid a low‑price, negative‑P/E stock.

Quanterix insider buy signals long‑term confidence: director’s 23k zero‑cost R‑stock units suggest optimism amid exec sell‑offs, hinting at future upside.